Invention Grant
- Patent Title: Azaindazoles useful as inhibitors of kinases
-
Application No.: US13193739Application Date: 2011-07-29
-
Publication No.: US08445681B2Publication Date: 2013-05-21
- Inventor: Guy Brenchley , Jean-Damien Charrier , Steven Durrant , Ronald Knegtel , Sharn Ramaya , Shazia Keily , Jingrong Cao
- Applicant: Guy Brenchley , Jean-Damien Charrier , Steven Durrant , Ronald Knegtel , Sharn Ramaya , Shazia Keily , Jingrong Cao
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Rory C. Stewart
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437
Abstract:
The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
Public/Granted literature
- US20120165367A1 AZAINDAZOLES USEFUL AS INHIBITORS OF KINASES Public/Granted day:2012-06-28
Information query
